Benzo[D]Thiazole

Benzo[D]Thiazole

SCHEMBL2404928

O=[N+]([O-])c1ccc2ncsc2c1.c1ccc2scnc2c1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
HSD17B10 Q99714 1/20 0.58
CYP3A4 P08684 3/20 0.47
HTT P42858 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
TSHR P16473 1/20 0.47
PDK1 Q15118 1/20 0.46
TXNRD1 Q16881 1/20 0.45
TXNRD3 Q86VQ6 1/20 0.45
TXNRD2 Q9NNW7 1/20 0.45
APP P05067 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP8 P22894 1/20 0.44
MMP13 P45452 1/20 0.44
PFKFB3 Q16875 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL393608 0.92 ALDH1A1 (0.53) ALDH1A1HSD17B10CYP3A4HTTSMN1; SMN2
Ammonia Solution, Strong SCHEMBL9639241 0.91 ALDH1A1 (0.51) ALDH1A1HSD17B10CYP3A4HTTSMN1; SMN2
Nitrobenzene SCHEMBL27909966 0.86 ALDH1A1 (0.63) ALDH1A1HSD17B10CYP3A4HTTTDP1
Sulfuric Acid SCHEMBL28605250 0.85 CA2 (0.49) ALDH1A1CYP3A4HTTSMN1; SMN2TDP1
SCHEMBL29517954 0.82 TXNRD1 (0.51) ALDH1A1HSD17B10CYP3A4HTTSMN1; SMN2
SCHEMBL1011755 0.82 TXNRD1 (0.51) ALDH1A1HSD17B10CYP3A4HTTSMN1; SMN2
SCHEMBL31106335 0.81 TXNRD1 (0.50) ALDH1A1HSD17B10CYP3A4HTTSMN1; SMN2
Benzo[D]Thiazole SCHEMBL28208335 0.80 ALDH1A1 (0.70) ALDH1A1HSD17B10CYP3A4TDP1APP
SCHEMBL30655029 0.76 ALDH1A1 (0.50) ALDH1A1CYP3A4HTTSMN1; SMN2TDP1
SCHEMBL15688963 0.76 ALDH1A1 (0.50) ALDH1A1CYP3A4HTTSMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110213124-A1 METHODS AND SYSTEMS FOR SYNTHESIS OF A D-AMINOLUCIFERIN PRECURSOR AND RELATED COMPOUNDS LAWRENCE LIVERMORE NATIONAL SECURITY, LLC 2011-09-01 US disclosed
EP-0423251-A4 ASSAY FOR QUALITATIVE AND QUANTITATIVE DETECTION OF ORGANIC AND INORGANIC ANALYTES OF DIVERSE CHEMICAL CLASSES VIA THE SELECTIVE FORMATION AND GROWTH OF LIGHT SCATTERING CRYSTALS 1993-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110213124-A1 METHODS AND SYSTEMS FOR SYNTHESIS OF A D-AMINOLUCIFERIN PRECURSOR AND RELATED COMPOUNDS HCCS, HLCS, GLUL ALDH1A1 2394/4885HSD17B10 2186/4885CYP3A4 754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.